Extended-Release Naltrexone vs. Buprenorphine-Naloxone for Preventing Opioid Relapse

被引:0
|
作者
不详
机构
关键词
D O I
10.1016/S01406736(17)32812-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:160 / 160
页数:1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse
    Murphy, Sean M.
    McCollister, Kathryn E.
    Leff, Jared A.
    Yang, Xuan
    Jeng, Philip J.
    Lee, Joshua D.
    Nunes, Edward V.
    Novo, Patricia
    Rotrosen, John
    Schackman, Bruce R.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (02) : 90 - +
  • [2] Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence A Randomized Clinical Noninferiority Trial
    Tanum, Lars
    Solli, Kristin Klemmetsby
    Latif, Zill-e-Huma
    Benth, Jurate Saltyte
    Opheim, Arild
    Sharma-Haase, Kamni
    Krajci, Peter
    Kunoe, Nikolaj
    JAMA PSYCHIATRY, 2017, 74 (12) : 1197 - 1205
  • [3] Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial
    Opheim, Arild
    Gaulen, Zhanna
    Solli, Kristin Klemmetsby
    Latif, Zill-e-Huma
    Fadnes, Lars T.
    Benth, Jurate Saltyte
    Kunoe, Nikolaj
    Tanum, Lars
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (05): : 453 - 460
  • [4] An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal
    Larochelle, Marc
    Yan, Shapei
    Christine, Paul
    Bovell-Ammon, Benjamin
    Bernson, Dana
    Liebschutz, Jane
    Walley, Alexander
    Novo, Patricia
    Lee, Joshua D.
    Rotrosen, John
    Lodi, Sara
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [5] An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal
    Larochelle, Marc
    Yan, Shapei
    Christine, Paul
    Hsu, Heather
    Bovell-Ammon, Benjamin
    Puppala, Radhika
    Bernson, Dana
    Liebschutz, Jane
    Walley, Alexander
    Novo, Patricia
    Lee, Joshua
    Rotrosen, John
    Lodi, Sara
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [6] Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among black adults
    Haeny, Angela M.
    Montgomery, LaTrice
    Burlew, A. Kathleen
    Campbell, Aimee N. C.
    Scodes, Jennifer
    Pavlicova, Martina
    Rotrosen, John
    Nunes, Edward
    ADDICTIVE BEHAVIORS, 2020, 110
  • [7] Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians
    Randesi, Matthew
    Rotrosen, John
    Nunes, Edward, V
    Lee, Joshua D.
    Novo, Patricia
    Levran, Orna
    Ott, Jurg
    Pavlicova, Martina
    Scodes, Jennifer
    Kreek, Mary Jeanne
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (06): : 761 - 768
  • [8] Depression and Suicidal Ideation in Adults With Opioid Use Disorder Treated With Buprenorphine-Naloxone Versus Extended-Release Naltrexone
    Rizk, Mina
    Stanley, Barbara
    Choo, Tse-Hwei
    Pavilcova, Martina
    Scodes, Jennifer
    Campbell, Aimee
    Nunes, Edward
    Rotrosen, John
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S268 - S269
  • [9] Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone
    Ruglass, Lesia M.
    Scodes, Jennifer
    Pavlicova, Martina
    Campbell, Aimee N. C.
    Fitzpatrick, Skye
    Barbosa-Leiker, Celestina
    Burlew, Kathleen
    Greenfield, Shelly F.
    Rotrosen, John
    Nunes, Edward V., Jr.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 205
  • [10] No Increase in Chronic Pain Among Opioid-Dependent individuals Randomized to Treatment With Extended-Release Naltrexone or Buprenorphine-Naloxone
    Latif, Zill-e-Huma
    Solli, Kristin
    Opheim, Arild
    Kunoe, Nikolaj
    Benth, Jurate
    Krajci, Peter
    Tanum, Lars
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S509 - S509